Sun Pharma Advanced Research Company Limited (SPARC.BO)
INR 214.15
(-1.81%)
INR 214.15
(-1.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.11 Billion INR | -85.39% |
| 2022 | -2.23 Billion INR | -14.06% |
| 2021 | -1.96 Billion INR | -34.57% |
| 2020 | -1.45 Billion INR | 53.74% |
| 2019 | -3.14 Billion INR | -107.05% |
| 2018 | -1.52 Billion INR | 39.34% |
| 2017 | -2.5 Billion INR | -91.76% |
| 2016 | -1.3 Billion INR | -85.69% |
| 2015 | -704.26 Million INR | -78.29% |
| 2014 | -395.01 Million INR | -211.89% |
| 2013 | 353.03 Million INR | 281.59% |
| 2012 | -194.41 Million INR | 72.99% |
| 2011 | -719.68 Million INR | -752.15% |
| 2010 | -84.45 Million INR | 60.48% |
| 2009 | -213.68 Million INR | -77.99% |
| 2008 | -120.05 Million INR | -163.98% |
| 2007 | -45.48 Million INR | -147.39% |
| 2006 | -18.38 Million INR | 0.0% |
| 2005 | - INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -965 Million INR | 11.39% |
| 2024 Q2 | -1.06 Billion INR | -9.92% |
| 2023 Q4 | -1.08 Billion INR | -2.95% |
| 2023 Q2 | -946.5 Million INR | 10.1% |
| 2023 Q1 | -1.05 Billion INR | -13.8% |
| 2023 FY | -4.14 Billion INR | -85.39% |
| 2023 Q3 | -1.05 Billion INR | -11.76% |
| 2022 FY | -2.23 Billion INR | -14.06% |
| 2022 Q1 | -809 Million INR | -17.16% |
| 2022 Q2 | -656 Million INR | 18.91% |
| 2022 Q3 | 130.5 Million INR | 119.89% |
| 2022 Q4 | -925.1 Million INR | -808.89% |
| 2021 FY | -1.96 Billion INR | -34.57% |
| 2021 Q1 | -568 Million INR | -7.11% |
| 2021 Q3 | -138.5 Million INR | 76.0% |
| 2021 Q2 | -577.1 Million INR | -1.6% |
| 2021 Q4 | -690.5 Million INR | -398.56% |
| 2020 FY | -1.45 Billion INR | 53.74% |
| 2020 Q1 | 586.6 Million INR | 159.88% |
| 2020 Q2 | -823.3 Million INR | -240.35% |
| 2020 Q3 | -641.2 Million INR | 22.12% |
| 2020 Q4 | -530.3 Million INR | 17.3% |
| 2019 FY | -3.14 Billion INR | -107.05% |
| 2019 Q1 | -936 Million INR | -462.23% |
| 2019 Q4 | -979.68 Million INR | -77.32% |
| 2019 Q3 | -552.5 Million INR | 12.18% |
| 2019 Q2 | -629.1 Million INR | 32.79% |
| 2018 Q1 | -644.6 Million INR | -38.65% |
| 2018 FY | -1.52 Billion INR | 39.34% |
| 2018 Q4 | -166.48 Million INR | 75.87% |
| 2018 Q3 | -690 Million INR | -2584.82% |
| 2018 Q2 | -25.7 Million INR | 96.01% |
| 2017 Q1 | -787.7 Million INR | -147.24% |
| 2017 FY | -2.5 Billion INR | -91.76% |
| 2017 Q4 | -464.9 Million INR | 19.91% |
| 2017 Q3 | -580.5 Million INR | 7.19% |
| 2017 Q2 | -625.5 Million INR | 20.59% |
| 2016 Q3 | -659.9 Million INR | -527.4% |
| 2016 FY | -1.3 Billion INR | -85.69% |
| 2016 Q4 | -318.6 Million INR | 51.72% |
| 2016 Q2 | 154.4 Million INR | 144.39% |
| 2016 Q1 | -347.8 Million INR | -320.05% |
| 2015 Q3 | -403.7 Million INR | -129.64% |
| 2015 Q2 | -175.8 Million INR | -998.75% |
| 2015 Q4 | -82.8 Million INR | 79.49% |
| 2015 FY | -704.26 Million INR | -78.29% |
| 2015 Q1 | -16 Million INR | 82.89% |
| 2014 Q4 | -93.51 Million INR | 50.39% |
| 2014 FY | -395.01 Million INR | -211.89% |
| 2014 Q3 | -188.5 Million INR | -1227.46% |
| 2014 Q2 | -14.2 Million INR | 85.33% |
| 2014 Q1 | -96.8 Million INR | -228.3% |
| 2013 Q4 | -29.48 Million INR | -108.07% |
| 2013 FY | 353.03 Million INR | 281.59% |
| 2013 Q2 | -55.8 Million INR | -146.81% |
| 2013 Q1 | 119.2 Million INR | -74.03% |
| 2013 Q3 | 365.3 Million INR | 754.66% |
| 2012 Q1 | -182 Million INR | 15.42% |
| 2012 Q3 | -228.6 Million INR | 2.27% |
| 2012 Q4 | 459.05 Million INR | 300.81% |
| 2012 FY | -194.41 Million INR | 72.99% |
| 2012 Q2 | -233.9 Million INR | -28.52% |
| 2011 Q3 | -178.4 Million INR | 0.0% |
| 2011 FY | -719.68 Million INR | -752.15% |
| 2011 Q4 | -215.18 Million INR | -20.62% |
| 2010 FY | -84.45 Million INR | 60.48% |
| 2009 FY | -213.68 Million INR | -77.99% |
| 2008 FY | -120.05 Million INR | -163.98% |
| 2007 FY | -45.48 Million INR | -147.39% |
| 2006 FY | -18.38 Million INR | 0.0% |
| 2005 FY | - INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 120.913% |
| Amrutanjan Health Care Limited | 457.54 Million INR | 999.376% |
| Sigachi Industries Limited | 1.47 Billion INR | 379.195% |
| Bal Pharma Limited | 233.9 Million INR | 1859.249% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 193.089% |
| Medico Remedies Limited | 100.3 Million INR | 4202.733% |
| Lasa Supergenerics Limited | -458 Million INR | -798.471% |
| Venus Remedies Limited | 534.65 Million INR | 869.669% |
| Alpa Laboratories Limited | 184.49 Million INR | 2330.411% |
| Nectar Lifesciences Limited | 923.8 Million INR | 545.444% |
| Shilpa Medicare Limited | 1.36 Billion INR | 401.188% |
| Aarti Drugs Limited | 7.14 Billion INR | 157.563% |
| Lupin Limited | 28.04 Billion INR | 114.673% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 109.751% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 109.546% |
| Windlas Biotech Limited | 1.29 Billion INR | 416.812% |
| Suven Life Sciences Limited | -1.22 Billion INR | -235.696% |
| Eris Lifesciences Limited | 5.18 Billion INR | 179.415% |
| Valiant Laboratories Limited | - INR | Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 128.811% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | -6.804% |
| Ipca Laboratories Limited | 7.98 Billion INR | 151.563% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 434.284% |
| Achyut Healthcare Limited | 4.43 Million INR | 92822.871% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 103.945% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | 279.516% |
| Mankind Pharma Limited | 21.51 Billion INR | 119.124% |
| Laurus Labs Limited | 3.94 Billion INR | 204.215% |
| Piramal Pharma Limited | 4.55 Billion INR | 190.304% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 1750.963% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 116.242% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 171.465% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 163.285% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Sequent Scientific Limited | - INR | Infinity% |
| Novartis India Limited | 626.5 Million INR | 756.83% |
| Wanbury Limited | 569.71 Million INR | 822.297% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 189.309% |
| Wockhardt Limited | -670 Million INR | -514.185% |
| Themis Medicare Limited | 392.58 Million INR | 1148.18% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 909.84% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 179.303% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 145.829% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 106.076% |
| Divi's Laboratories Limited | 33.08 Billion INR | 112.44% |
| NATCO Pharma Limited | 25.96 Billion INR | 115.85% |
| Gufic Biosciences Limited | 1.32 Billion INR | 409.423% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 357.705% |
| Ind-Swift Limited | 1.22 Billion INR | 435.658% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 247.704% |
| FDC Limited | 2.98 Billion INR | 237.801% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | -2608.03% |
| Granules India Limited | 6.81 Billion INR | 160.367% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 121.144% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 339.595% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | 45476.305% |
| Brooks Laboratories Limited | 14.44 Million INR | 28597.514% |
| Megasoft Limited | -121.1 Million INR | -3297.94% |
| ZIM Laboratories Limited | 253.82 Million INR | 1721.186% |
| Strides Pharma Science Limited | 5.22 Billion INR | 178.745% |
| Neuland Laboratories Limited | 5.31 Billion INR | 177.378% |
| Morepen Laboratories Limited | 4.17 Billion INR | 198.591% |
| Hikal Limited | 32.11 Million INR | 12915.45% |
| Indoco Remedies Limited | 1.29 Billion INR | 418.366% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 231.55% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 2077.91% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 15086.674% |
| Hester Biosciences Limited | 364.81 Million INR | 1227.996% |